Kevin C. Zorn MD, FRCSC, FACSAssociate Professor of Urology, Director of Robotic Surgery, University of Montreal Hospital Center, Montreal, QC, Canada
Dr. Kevin Zorn is a dual-board-certified (US and Canada), minimally-invasive urologist, oncology-fellowship trained at the University of Chicago. As a native Montrealer, Dr. Zorn received his undergraduate and MD degrees from McGill University where he completed his residency in urology in 2005. His main focus of clinical and scientific interest is in the surgical treatment of benign prostatic hyperplasia (BPH) and prostate cancer. Other than his focus on robotic surgery with over 2500 robotic prostatectomy cases performed, Dr. Zorn is also the national Canadian surgical trainer and international proctor for the Greenlight XPS 180W laser since 2012. He has also an active proctor from residents to international urologists with integration of simulation experience. He has also been an invited speaker/visiting professor for his academic work on laser therapies and techniques for BPH management. He was the first in Canada to utilize the latest version of the Greenlight 180W XPS laser for BPH and has pioneered an enucleation-like technique to standardize Greenlight technique. Not only has Dr. Zorn helped with the national BPH guidelines, he is also an active with various other minimally invasive therapies with Urolift, Rezum, Aquablation and other cutting edge technologies including Optilume and Zenflow.
Dr. Zorn is an active researcher and a dedicated teacher to his urology residents and fellows. He has published extensively on prostate surgical care with over 250 peer-reviewed papers and 12 book chapters (http://www.ncbi.nlm.nih.gov/pubmed?term=zorn%20kc). He has received awards for his clinical work, research and teaching from the AUA and Endourological Society. He is also a reviewer for many urological journals and has been awarded Best Reviewer for Prostate Cancer in 2009 and 2010 for the Journal of Urology. He has also been a member of the American Urological Association (AUA) educational task force for the development of the laparoscopic and robotic urologic surgery curriculum and has served AUA hands-on course director for the annual AUA annual meetings for 7 years. Dr. Zorn has also helped develop and organize the University of Chicago Robotic Radical Prostatectomy Course (a symposium of the world's top robotic surgeons) which began in 2007. He has worked closely with AMS/BSCI through center of excellence (COE) training activities to foster Greenlight XPS training. Most recently, he has been invited as a member of the CUA BPH Guidelines Committee as well as the CUA continuing professional development (CPD) Committee. As such, Dr. Zorn has a passion for academics and peer-related education.
Over the past 10 years, Dr. Zorn has returned home to Montreal to develop the University of Montreal (CHUM) robotic and laser BPH program. He serves as Associate Professor of Surgery and Director of Robotic Surgery.